Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Perspectives

The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand's pharmaceutical benefit package

         
Total article views   Abstract views HTML views PDF downloads Totals
8,834 Dovepress* 7,104 645+ 1,928 7,749
PubMed Central* 0 1,085 352 1,085
Totals 7,104 1,730 2,280 8,834
*Since 6 December 2012
+Since July 2016

View citations on PubMed Central and Google Scholar